These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2999503)

  • 21. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage.
    Brand HS; van Kampen GP; van der Korst JK
    Clin Exp Rheumatol; 1990; 8(4):393-5. PubMed ID: 2397627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
    Ohno I; Ida S
    Nihon Rinsho; 1987 Mar; 45(3):577-82. PubMed ID: 3298736
    [No Abstract]   [Full Text] [Related]  

  • 25. Quinolones in vitro.
    Willems FT
    Pharm Weekbl Sci; 1986 Feb; 8(1):26-8. PubMed ID: 3960690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action of quinolones].
    Smith JT
    Infection; 1986; 14 Suppl 1():S3-15. PubMed ID: 2420724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Variations in vitro of the efficacy of quinolones as a function of pH].
    François B; Gille Y; Schmuck N; Assenat H; Adeleine P; Davoine P
    Nephrologie; 1983; 4(6):259-62. PubMed ID: 6669186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane permeability of Pseudomonas aeruginosa to 4-quinolones.
    Kubesch P; Wehsling M; Tümmler B
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):197-202. PubMed ID: 3118593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyclic and tricyclic analogs of quinolones: mechanism of action.
    Georgopapadakou NH; Dix BA; Angehrn P; Wick A; Olson GL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):614-6. PubMed ID: 3037999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A; Ullmann U
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():33-8. PubMed ID: 6238931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates.
    Galante D; Pennucci C; Esposito S; Barba D
    Drugs Exp Clin Res; 1985; 11(5):331-4. PubMed ID: 2941260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Action of quinolones on gene expression and bacterial membranes.
    Dalhoff A; Döring G
    Antibiot Chemother (1971); 1987; 39():205-14. PubMed ID: 2823690
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.
    Meier-Ewert H; Weil G; Millott G
    Eur J Clin Microbiol; 1984 Aug; 3(4):372. PubMed ID: 6593220
    [No Abstract]   [Full Text] [Related]  

  • 36. Mutational resistance to 4-quinolone antibacterial agents.
    Smith JT
    Eur J Clin Microbiol; 1984 Aug; 3(4):347-50. PubMed ID: 6237904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin (BAY O 9867). Comparative in vitro activity study.
    Canton E; Garcia J; Vila B; Santos M; Gobernado M
    Microbiol Esp; 1984; 37(3-4):73-9. PubMed ID: 6242123
    [No Abstract]   [Full Text] [Related]  

  • 38. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
    Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of conjugal transfer by new quinolinic compounds.
    Oliva B; Selan L; Ravagnan G; Renzini G
    Chemioterapia; 1985 Jun; 4(3):199-201. PubMed ID: 3161641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International experiences with ofloxacin, a new quinolone.
    Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.